Qilu Pharmaceutical (Hainan) Co., Ltd. clinical trials
A subsidiary of Qilu Pharmaceutical Co., Ltd.
The registry lists 8 studies whose lead sponsor is Qilu Pharmaceutical (Hainan) Co., Ltd.. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 14, 2026.
Where
- China
- 3
Registry sponsor names on this page
- Qilu Pharmaceutical (Hainan) Co., Ltd.8 studies
Something wrong with this grouping? Tell us on the Qilu Pharmaceutical Co., Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 8 of 8. All Qilu Pharmaceutical Co., Ltd. studies →
- QLM2010 Comparative Pharmacokinetic Study With 2-Minute Intravenous AdministrationNot yet recruitingNCT07817004Phase 1
Sponsor listed in the registry: Qilu Pharmaceutical (Hainan) Co., Ltd.
- A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS)Not yet recruitingNCT07138833Phase 4
Sponsor listed in the registry: Qilu Pharmaceutical (Hainan) Co., Ltd.
- A Study of QLM2011 in Subjects With Advanced Solid TumorsNot yet recruitingNCT06925659Phase 1
Sponsor listed in the registry: Qilu Pharmaceutical (Hainan) Co., Ltd.
- Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe PruritusRecruitingNCT06446310Phase 3
Sponsor listed in the registry: Qilu Pharmaceutical (Hainan) Co., Ltd.
- a Study Evaluating the Safety and Efficacy of Clevidipine for Patients Who With Hypertensive Emergency and Sub-emergencyNot yet recruitingNCT05922436Phase 3
Sponsor listed in the registry: Qilu Pharmaceutical (Hainan) Co., Ltd.
- Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and VomitingCompletedNCT06932107Phase 3
Sponsor listed in the registry: Qilu Pharmaceutical (Hainan) Co., Ltd.
- A Comparison of the Efficacy of Amisulpride and Placebo in the Prevention of PONV in Patients at Moderate-to-high Risk of PONV.Status unknownNCT05822713Phase 3
Sponsor listed in the registry: Qilu Pharmaceutical (Hainan) Co., Ltd.
- A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated PainStatus unknownNCT05648669Phase 3
Sponsor listed in the registry: Qilu Pharmaceutical (Hainan) Co., Ltd.